BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang YQ, Jiang LJ, Jiang SX, Xu YF, Zhou BB, Huang GH, Liu DM, Wang Y, Fan WZ, Li JP, Wang B. Gefitinib with or without Transarterial Infusion Chemotherapy (Cisplatin) for Large Nonsmall Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations. J Vasc Interv Radiol 2019;30:1004-12. [PMID: 31171399 DOI: 10.1016/j.jvir.2018.12.705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu J, Xu L, Wang B, Kong W, Chen Y, Yu Z. Outcomes in Patients With Lung Adenocarcinoma With Transformation to Small Cell Lung Cancer After EGFR Tyrosine Kinase Inhibitors Resistance: A Systematic Review and Pooled Analysis. Front Oncol 2021;11:766148. [PMID: 35223450 DOI: 10.3389/fonc.2021.766148] [Reference Citation Analysis]
2 Wang J, Zhang X, Yang F, Yang Y, Wang T, Liu W, Zhou H, Zhao W. RASSF1A Enhances Chemosensitivity of NSCLC Cells Through Activating Autophagy by Regulating MAP1S to Inactivate Keap1-Nrf2 Pathway. Drug Des Devel Ther 2021;15:21-35. [PMID: 33442234 DOI: 10.2147/DDDT.S269277] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ryan SL, Dave KA, Beard S, Gyimesi M, McTaggart M, Sahin KB, Molloy C, Gandhi NS, Boittier E, O'Leary CG, Shah ET, Bolderson E, Baird AM, Richard DJ, O'Byrne KJ, Adams MN. Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer. Front Oncol 2021;11:615967. [PMID: 33777753 DOI: 10.3389/fonc.2021.615967] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ryan SL, Beard S, Barr MP, Umezawa K, Heavey S, Godwin P, Gray SG, Cormican D, Finn SP, Gately KA, Davies AM, Thompson EW, Richard DJ, O'Byrne KJ, Adams MN, Baird AM. Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC. Lung Cancer 2019;135:217-27. [PMID: 31446998 DOI: 10.1016/j.lungcan.2019.07.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]